Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06220396 · ClinicalTrials.gov registry record · NA

CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study

A NA study of Healthy, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06220396: Recruiting NA study of Healthy, sponsored by Mayo Clinic.

NCT06220396 is a NA study of Healthy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06220396, a NA study of Healthy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate pulmonary capillary wedge pressure (PCWP) and other hemodynamic measurements at rest and during exercise in healthy volunteers across the age spectrum.

Primary Outcome

Pulmonary capillary wedge pressure is a measure of cardiac filling pressure, measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter at rest.

Conditions Studied

Interventions

  • PROCEDURE Magnetic Resonance Imaging (MRI)
  • PROCEDURE Right Heart Catheterization with Hemodynamics and Limited Echocardiogram
  • PROCEDURE Dual X-ray absorptiometry (DEXA) scan

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-01-22
Est. Completion 2029-01
Phase NA
Mayo Clinic

2,844 total trials

What NCT06220396 shows while recruiting

NCT06220396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT06220396 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06220396 about?

NCT06220396 is a clinical study titled "CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study". The purpose of this study is to evaluate pulmonary capillary wedge pressure (PCWP) and other hemodynamic measurements at rest and during exercise in healthy volunteers across the age spectrum.

What is the current status of trial NCT06220396?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-01-22. Estimated completion is 2029-01.

What conditions does trial NCT06220396 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06220396?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Right Heart Catheterization with Hemodynamics and Limited Echocardiogram (PROCEDURE), Dual X-ray absorptiometry (DEXA) scan (PROCEDURE).

Who is sponsoring clinical trial NCT06220396?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06220396 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06220396's enrollment target sits among peer trials

80 274th of 1090 higher than 802 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06220396, the US trial registry maintained by the National Library of Medicine. NCT06220396 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.